104 related articles for article (PubMed ID: 23153456)
21. Amplification of the signal transducer and activator of transcription I signaling pathway and its association with apoptosis in monocytes from HIV-infected patients.
Alhetheel A; Yakubtsov Y; Abdkader K; Sant N; Diaz-Mitoma F; Kumar A; Kryworuchko M
AIDS; 2008 Jun; 22(10):1137-44. PubMed ID: 18525259
[TBL] [Abstract][Full Text] [Related]
22. STAT5 activation by human GH protects insulin-producing cells against interleukin-1beta, interferon-gamma and tumour necrosis factor-alpha-induced apoptosis independent of nitric oxide production.
Jensen J; Galsgaard ED; Karlsen AE; Lee YC; Nielsen JH
J Endocrinol; 2005 Oct; 187(1):25-36. PubMed ID: 16214938
[TBL] [Abstract][Full Text] [Related]
23. IFNalpha and IFNlambda differ in their antiproliferative effects and duration of JAK/STAT signaling activity.
Maher SG; Sheikh F; Scarzello AJ; Romero-Weaver AL; Baker DP; Donnelly RP; Gamero AM
Cancer Biol Ther; 2008 Jul; 7(7):1109-15. PubMed ID: 18698163
[TBL] [Abstract][Full Text] [Related]
24. Apical role for BRG1 in cytokine-induced promoter assembly.
Ni Z; Karaskov E; Yu T; Callaghan SM; Der S; Park DS; Xu Z; Pattenden SG; Bremner R
Proc Natl Acad Sci U S A; 2005 Oct; 102(41):14611-6. PubMed ID: 16195385
[TBL] [Abstract][Full Text] [Related]
25. T-bet is a STAT1-induced regulator of IL-12R expression in naïve CD4+ T cells.
Afkarian M; Sedy JR; Yang J; Jacobson NG; Cereb N; Yang SY; Murphy TL; Murphy KM
Nat Immunol; 2002 Jun; 3(6):549-57. PubMed ID: 12006974
[TBL] [Abstract][Full Text] [Related]
26. Altered interferon-alpha-signaling in natural killer cells from patients with chronic hepatitis C virus infection.
Miyagi T; Takehara T; Nishio K; Shimizu S; Kohga K; Li W; Tatsumi T; Hiramatsu N; Kanto T; Hayashi N
J Hepatol; 2010 Sep; 53(3):424-30. PubMed ID: 20554341
[TBL] [Abstract][Full Text] [Related]
27. IRF-9/STAT2 [corrected] functional interaction drives retinoic acid-induced gene G expression independently of STAT1.
Lou YJ; Pan XR; Jia PM; Li D; Xiao S; Zhang ZL; Chen SJ; Chen Z; Tong JH
Cancer Res; 2009 Apr; 69(8):3673-80. PubMed ID: 19351818
[TBL] [Abstract][Full Text] [Related]
28. Role of STAT3 in type I interferon responses. Negative regulation of STAT1-dependent inflammatory gene activation.
Ho HH; Ivashkiv LB
J Biol Chem; 2006 May; 281(20):14111-8. PubMed ID: 16571725
[TBL] [Abstract][Full Text] [Related]
29. Desferrioxamine, an iron chelator, inhibits CXCL10 expression induced by polyinosinic-polycytidylic acid in U373MG human astrocytoma cells.
Imaizumi T; Sakashita N; Mushiga Y; Yoshida H; Hayakari R; Xing F; Wang L; Matsumiya T; Tanji K; Chiba Y; Furudate K; Kawaguchi S; Murakami M; Tanaka H
Neurosci Res; 2015 May; 94():10-6. PubMed ID: 25591911
[TBL] [Abstract][Full Text] [Related]
30. IL-27 is expressed in chronic human eczematous skin lesions and stimulates human keratinocytes.
Wittmann M; Zeitvogel J; Wang D; Werfel T
J Allergy Clin Immunol; 2009 Jul; 124(1):81-9. PubMed ID: 19523673
[TBL] [Abstract][Full Text] [Related]
31. Cooperation between the bacterial-derived short-chain fatty acid butyrate and interleukin-22 detected in human Caco2 colon epithelial/carcinoma cells.
Bachmann M; Meissner C; Pfeilschifter J; Mühl H
Biofactors; 2017 Mar; 43(2):283-292. PubMed ID: 27801948
[TBL] [Abstract][Full Text] [Related]
32. Interleukin-27 displays interferon-gamma-like functions in human hepatoma cells and hepatocytes.
Bender H; Wiesinger MY; Nordhoff C; Schoenherr C; Haan C; Ludwig S; Weiskirchen R; Kato N; Heinrich PC; Haan S
Hepatology; 2009 Aug; 50(2):585-91. PubMed ID: 19582813
[TBL] [Abstract][Full Text] [Related]
33. Interferon-α induces neurotoxicity through activation of the type I receptor and the GluN2A subunit of the NMDA receptor.
Kessing CF; Tyor WR
J Interferon Cytokine Res; 2015 Apr; 35(4):317-24. PubMed ID: 25517826
[TBL] [Abstract][Full Text] [Related]
34. The effect of interferon-α on the expression of cytochrome P450 3A4 in human hepatoma cells.
Flaman AS; Gravel C; Hashem AM; Tocchi M; Li X
Toxicol Appl Pharmacol; 2011 Jun; 253(2):130-6. PubMed ID: 21466820
[TBL] [Abstract][Full Text] [Related]
35. STAT1-dependent and STAT1-independent gene expression in murine immune cells following stimulation with interferon-alpha.
Zimmerer JM; Lesinski GB; Radmacher MD; Ruppert A; Carson WE
Cancer Immunol Immunother; 2007 Nov; 56(11):1845-52. PubMed ID: 17503042
[TBL] [Abstract][Full Text] [Related]
36. Interferon-alpha promotes immunosuppression through IFNAR1/STAT1 signalling in head and neck squamous cell carcinoma.
Ma H; Yang W; Zhang L; Liu S; Zhao M; Zhou G; Wang L; Jin S; Zhang Z; Hu J
Br J Cancer; 2019 Feb; 120(3):317-330. PubMed ID: 30555157
[TBL] [Abstract][Full Text] [Related]
37. Interleukin-26, a highly cationic T-cell cytokine targeting epithelial cells.
Braum O; Pirzer H; Fickenscher H
Antiinflamm Antiallergy Agents Med Chem; 2012; 11(3):221-9. PubMed ID: 23106140
[TBL] [Abstract][Full Text] [Related]
38. STAT1 activation represses IL-22 gene expression and psoriasis pathogenesis.
Bai L; Fang H; Xia S; Zhang R; Li L; Ochando J; Xu J; Ding Y
Biochem Biophys Res Commun; 2018 Jun; 501(2):563-569. PubMed ID: 29750958
[TBL] [Abstract][Full Text] [Related]
39. IFNα signaling through PKC-θ is essential for antitumor NK cell function.
Comet NR; Aguiló JI; Rathoré MG; Catalán E; Garaude J; Uzé G; Naval J; Pardo J; Villalba M; Anel A
Oncoimmunology; 2014; 3(8):e948705. PubMed ID: 25960930
[TBL] [Abstract][Full Text] [Related]
40. Type I interferons exert anti-tumor effect via reversing immunosuppression mediated by mesenchymal stromal cells.
Shou P; Chen Q; Jiang J; Xu C; Zhang J; Zheng C; Jiang M; Velletri T; Cao W; Huang Y; Yang Q; Han X; Zhang L; Wei L; Rabson AB; Chin YE; Wang Y; Shi Y
Oncogene; 2016 Nov; 35(46):5953-5962. PubMed ID: 27109100
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
